Keyword: Sovaldi

gilead

5. Gilead Sciences

Gilead Sciences could at one time do no wrong, but then sales of its hep C meds slowed and it hit some major trial setbacks. Now, the biotech faces increasingly loud questions about what its next Big Thing will be.